openPR Logo
Press release

Acute Myeloid Leukemia Market Growth by 2021

05-29-2018 03:14 PM CET | Health & Medicine

Press release from: Persistence Market Research

Acute Myeloid Leukemia (AML) is classed as an orphans disease. AML is a rare but a severe disease and is a most common leukemia. It is primarily a disease of the elderly, with an average age of diagnosis of approximately 66. AML results from the acquired changes in the DNA of a developing marrow cell. The marrow cells get converted into the leukemic cells, multiplies into 11 billion or more. AML affects the normal cells which are partially developed and further these cells are unable to perform their functions. These cells are known as leukemia blasts. Leukemia blast grows and survives better than normal cells and also blocks the production of normal cells.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/7454

AML is developed in an individual due to the recurrent exposure to element benzene since benzene damages the DNA of a normal marrow cells. As per the Toxic Substance and Disease registry, petroleum products contributes to the majority of benzene in atmosphere half of the exposure to benzene comes from cigarette smoke. AML cases are also seen in patients undergoing chemotherapy (alkylating agents or topoisomerase II inhibitors) or radiation therapy. People with genetic disorders such as Shwachman syndrome, Down syndrome, Diamond Blackfan Syndrome are associated with a risk of AML. Also people with certain blood disorder can develop AML.

According to the American Cancer Society of U.S.A (2015) states that around 54,270 new cases of all kind of Leukemia were detected in 2015, out of which 20,830 cases were found to be of AML and 10,640 deaths were due to AML and. It also states that AML is found to be more common in men than in women.

The segmentation of Acute Myeloid Leukemia market is done on the basis of drugs, pipeline analysis and geography. On the basis of drugs it is classified as Daunorubicin, Vidaza, Dagogen, Busulfan, Idarubicin and Others The pipeline analysis is a complete evaluation of the pipeline for AML treatments, with specific analysis of a number of late stage (phase III) pipeline drugs that have the potential to enter the market during the forecast period and early stage (Phase I and Phase II) also. The pipeline is evaluated on the origin of phase distribution, molecule targets, molecular types and administration routes. An added in-depth examination of pipeline drug clinical trials by phase, trial size and trial duration On the basis of the geography, the acute myeloid leukemia market can be classified into North America, Asia Pacific, Latin America, Europe, and Rest of the World. The market of AML is dominated by North America and is followed by Europe and Asia Pacific. North America is reported to have the largest market share due to the aging population and the maximum cases of AML being detected.

The AML market will grow faster in the coming years due to the rising exposure to benzene, increasing incidences of chemotherapy and radiation therapy, Novel drug therapies, increasing aging population and the unmet needs of the market. Whereas increasing number of stem cell transplant, lack of standardized treatment and market being heavily dominated with the generics act as a barrier in the AML market.

Request a Sample Brochure of the Report @ https://www.persistencemarketresearch.com/samples/7454

The major players in AML market are Johnson & Johnson Private Limited, Pfizer Inc. Abbott, AstraZeneca, Bayer, Celgene Corporation, Ambit Biosciences Corporation, Cyclacel Pharmaceuticals Inc. Novartis AG and Sanofi.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Myeloid Leukemia Market Growth by 2021 here

News-ID: 1065030 • Views: 481

More Releases from Persistence Market Research

Plantbased Protein Market to Witness Rise in Revenues During the Period 2019 - 2 …
Persistence Market Research has published a report on the plant-based protein market, which includes the global industry analysis for 2014-2018 and opportunity assessment for 2019-2029, and projects that the global plant-based protein market is expected to reach ~ US$ 9.6 Bn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 17.3 Bn by the end of 2029. According to the report, proteins are
The Chained Consumer Foodservice Market To Grasp Through The Fine Courses Of Nov …
The latest study by Persistence Market Research opines that the global chained consumer foodservice market is more popular than ever with paradigm changes in the way guests are eating and receiving their food. The chained consumer foodservice service market is expected to grow by around 4% over the forecast years, producing over US$ 280 Bn of incremental value from 2019 to 2027. This is partly driven by technology and mobile
New Product Launches To Put The Natural Organic Personal Care Product Market In …
The global natural and organic personal care products market was valued at ~US$ 10 Bn in 2014, which is estimated to reach ~US$ 14 Bn by the end of 2019. The natural and organic personal care products market is projected to expand at a robust CAGR during the next decade. Persistence Market Research (PMR) recently released a new market research on the natural and organic personal care products market covering
The Digestive Remedies Market To Ride On The Curve Of Innovation
According to a recently published PMR report, global digestive remedies market in 2018 exceeded US$ 15 Bn and is expected to grow at a moderate CAGR during the forecast period. Digestive remedies such as probiotics are used for therapy of gastrointestinal (GI) illnesses. The most prevalent digestive disorders include indigestion, heartburn, diarrhea, irritable bowel syndrome (IBS), movement disease, pediatric digestive illnesses, and constipation. To remain ‘ahead’ of your competitors, request

All 5 Releases


More Releases for AML

ALSEGO’s New Automated AML Reporting Solution for Luxembourgish Banks
ALSEGO has launched a new automated AML Reporting solution aimed specifically at financial institutions in Luxembourg concerned with the Central Electronic Data Retrieval System (CEDRS) as stipulated in the CSSF circular 20/747. The solution is fully automated, however, if you wish to forgo a direct connection between the solution and your core-banking system, the solution functions with TSV/CSV files as well. The automatic functionalities of the solution are its key strengths.
Global AML Software Market Size, Status and Forecast
AML software is software used in the finance and legal industries to meet the legal requirements for financial institutions and other regulated entities to prevent or report money laundering activities. Europe to be the largest market for AML software during the forecast period. Though the Europe accounts for the largest market share, the APAC region is envisaged to witness the fastest growth during the predicted period. United States will still
Global AML Software Market Size, Status, Trends, Growth, Size, Segmentation, Sha …
The market for AML Software Market is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global AML Software Market Size, Status and Forecast 2018-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions.
Global Anti-money Laundering Software Market 2015 | Major Key Players : ACI Worl …
Description : Technavio’s market research analyst predicts the global anti-money laundering (AML) software market to grow steadily at a CAGR of around 11% during the forecast period. AML software allows financial institutions and other enterprises to detect suspicious transactions and analyze customer data. Its ability to provide real-time alerts and tools to report suspicious events to maximize security and operational efficiency will foster its adoption during the forecast period. An important growth
Anti-money Laundering Software Global Market 2018: Key Players – ACI Worldwide …
Anti-money Laundering Software Industry Description Wiseguyreports.Com Adds “Anti-money Laundering Software -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies Anti-money Laundering Software in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering ACI Worldwide AML360 AML Partners AML RightSource BAE EastNets Experian
Acute Myeloid Leukemia (AML) Therapeutics Market to Develop Rapidly by 2025
Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection. Leukemia can grow along either the myeloid or lymphoid stem cell lines, it